Why the study?
Ischemic late gadolinium enhancement lesions are prevalent in diabetes, but non-ischemic late gadolinium enhancement lesions had not previously been described or systematically studied in this population.
A specific pattern of non-ischemic mid-myocardial LGE is present in nearly 10% of patients with type 2 diabetes and is associated with adverse cardiac remodeling and diabetic complications.
Answers are grounded in this paper and cite their sources.
Non-ischemic basal lateral LGE occurs in T2DM; hypothesis-generating for fibrosis screening and outcome studies.
Background: Cardiovascular magnetic resonance imaging (CMR) have described localised non-ischemic late gadolinium enhancement (LGE) lesions of prognostic importance in various non-ischemic cardiomyopathies. Ischemic LGE lesions are prevalent in diabetes (DM), but non-ischemic LGE lesions have not previously been described or systematically studied in DM. Methods: 296 patients with type 2 DM (T2DM) and 25 sex-matched control subjects underwent echocardiography and CMR including adenosine-stress perfusion, T 1 -mapping and LGE. Results: 264 patients and all control subjects completed the CMR protocol. 78.4% of patients with T2DM had no LGE lesions; 11.0% had ischemic LGE lesions only; 9.5% had non-ischemic LGE lesions only; and 1.1% had both one ischemic and one non-ischemic lesion. The non-ischemic LGE lesions were situated mid-myocardial in the basal lateral or the basal inferolateral part of the left ventricle and the affected segments showed normal to high wall thickness and normal contraction. Patients with non-ischemic LGE lesions in comparison with patients without LGE lesions had increased myocardial mass (150±34 vs . 133±33 g, P=0.02), average E/e’(9.9 IQR8.7-12.6 vs . 8.8 IQR7.4-10.7, P=0.04), left atrial maximal volume (102 IQR84.6-115.2 vs . 91 IQR75.2-100.0 mL, P=0.049), NT-proBNP (8.9 IQR5.9-19.7 vs . 5.9 IQR5.9-10.1 µmol/L, P=0.02) and high-sensitive troponin (15.6 IQR13.0-26.1 vs . 13.0 IQR13.0-14.6 ng/L, P=0.007) and a higher prevalence of retinopathy (48 vs . 25 %, p=0.009) and autonomic neuropathy (52 vs. 30.5%, P=0.005). Conclusion A specific LGE pattern with lesions in the basal lateral or the basal inferolateral part of the left ventricle was found in patients with type 2 diabetes. Clinical trial registration: www.clinicaltrials.gov. Unique identifier: NCT02684331.
No takes yet. Share an insight, caveat, or question.
Bojer et al. (2020) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: